Home LiteratureArticle Details
PMID: 19330026 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.

Oncogene ·Vol. 28 ·No. 17 ·2009-04-30 ·Pages 1892-903

Kwek SS, Roy R, Zhou H, Climent J, Martinez-Climent JA, Fridlyand J, Albertson DG

Abstract

Co-amplification at chromosomes 8p11-8p12 and 11q12-11q14 occurs often in breast tumors, suggesting possible cooperation between genes in these regions in oncogenesis. We used high-resolution array comparative genomic hybridization (array CGH) to map the minimal amplified regions. The 8p and 11q amplicons are complex and consist of at least four amplicon cores at each site. Candidate oncogenes mapping to these regions were identified by combining copy number and RNA and protein expression analyses. These studies also suggested that CCND1 at 11q13 induced expression of ZNF703 mapping at 8p12, which was subsequently shown to be mediated by the Rb/E2F pathway. Nine candidate oncogenes from 8p12 and four from 11q13 were further evaluated for oncogenic function. None of the genes individually promoted colony formation in soft agar or collaborated with each other functionally. On the other hand, FGFR1 and DDHD2 at 8p12 cooperated functionally with MYC, whereas CCND1 and ZNF703 cooperated with a dominant negative form of TP53. These observations highlight the complexity and functional consequences of the genomic rearrangements that occur in these breast cancer amplicons, including transcriptional cross-talk between genes in the 8p and 11q amplicons, as well as their cooperation with major pathways of tumorigenesis.

MeSH Terms
Breast Neoplasms/genetics,pathology Carrier Proteins/genetics Cell Line, Tumor Chromosomes, Human, Pair 11/genetics Chromosomes, Human, Pair 8/genetics Comparative Genomic Hybridization Cyclin D1/genetics Epistasis, Genetic Female Gene Amplification Gene Dosage Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Humans Neoplastic Stem Cells/metabolism,pathology Oncogene Protein p55(v-myc)/genetics Oncogenes/genetics Phospholipases/genetics RNA, Small Interfering/genetics Receptor, Fibroblast Growth Factor, Type 1/genetics Reverse Transcriptase Polymerase Chain Reaction Signal Transduction/genetics Transfection Tumor Suppressor Protein p53/genetics
Chemicals
CCND1 protein, human Carrier Proteins Oncogene Protein p55(v-myc) RNA, Small Interfering TP53 protein, human Tumor Suppressor Protein p53 ZNF703 protein, human Cyclin D1 FGFR1 protein, human Receptor, Fibroblast Growth Factor, Type 1 Phospholipases DDHD2 protein, human
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Kwek S S
Cancer Research Institute, University of California San Francisco, San Francisco, CA 94143-0808, USA.
Roy R
Zhou H
Climent J
Martinez-Climent J A
Fridlyand J
Albertson D G
References (42)
42 references, click to expand
  1. Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer.
    Genes Chromosomes Cancer. 1994 Jan;9(1):42-8 PMID: 7507699
  2. Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia.
    Blood. 1999 Mar 1;93(5):1677-83 PMID: 10029597
  3. NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
    Oncogene. 2005 Nov 10;24(49):7281-9 PMID: 16027731
  4. Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways.
    Int J Cancer. 2007 Sep 15;121(6):1265-73 PMID: 17520678
  5. MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
    Int J Cancer. 2002 Dec 20;102(6):608-14 PMID: 12448002
  6. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer.
    Cancer Res. 2006 Dec 15;66(24):11632-43 PMID: 17178857
  7. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model.
    J Cell Biol. 2005 Nov 21;171(4):663-73 PMID: 16301332
  8. High-resolution genomic and expression analyses of copy number alterations in breast tumors.
    Genes Chromosomes Cancer. 2008 Jun;47(6):530-42 PMID: 18335499
  9. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway.
    Cancer Res. 2003 Jan 15;63(2):424-31 PMID: 12543798
  10. Genome screening by comparative genomic hybridization.
    Trends Genet. 1997 Oct;13(10):405-9 PMID: 9351342
  11. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.
    Cancer Cell. 2006 Dec;10(6):515-27 PMID: 17157791
  12. Linear models and empirical bayes methods for assessing differential expression in microarray experiments.
    Stat Appl Genet Mol Biol. 2004;3:Article3 PMID: 16646809
  13. Correlation between p53 mutation and cyclin D1 amplification in had and neck squamous cell carcinoma.
    Oral Oncol. 1997 Jan;33(1):42-6 PMID: 9192552
  14. Human breast cancer cell lines as models of growth regulation and disease progression.
    J Mammary Gland Biol Neoplasia. 1996 Jan;1(1):111-21 PMID: 10887484
  15. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.
    Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12 PMID: 18077431
  16. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
    Cancer Res. 2008 Sep 1;68(17):7165-75 PMID: 18757432
  17. Genomic organization of the 8p11-p12 amplicon in three breast cancer cell lines.
    Cancer Genet Cytogenet. 2004 Nov;155(1):57-62 PMID: 15527903
  18. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
    Anticancer Res. 1997 Nov-Dec;17(6D):4387-94 PMID: 9494538
  19. Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event.
    Genes Chromosomes Cancer. 2007 May;46(5):427-39 PMID: 17285574
  20. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.
    Oncogene. 2005 Jun 16;24(26):4232-42 PMID: 15824737
  21. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media.
    Cancer Res. 1993 Feb 1;53(3):627-35 PMID: 8425198
  22. Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma.
    Cytogenet Cell Genet. 1997;79(1-2):125-31 PMID: 9533029
  23. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.
    Clin Cancer Res. 2006 Nov 15;12(22):6652-62 PMID: 17121884
  24. Integrated profiling of basal and luminal breast cancers.
    Cancer Res. 2007 Dec 15;67(24):11565-75 PMID: 18089785
  25. Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer.
    Cancer Res. 2007 Jan 15;67(2):818-26 PMID: 17234794
  26. Breast tumor copy number aberration phenotypes and genomic instability.
    BMC Cancer. 2006 Apr 18;6:96 PMID: 16620391
  27. Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma.
    Breast Cancer Res Treat. 2001 Feb;65(3):225-32 PMID: 11336244
  28. A 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.
    Oncogene. 2005 Aug 4;24(33):5235-45 PMID: 15897872
  29. Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.
    Cancer Res. 2004 Dec 1;64(23):8541-9 PMID: 15574760
  30. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Exp Mol Pathol. 2006 Oct;81(2):115-22 PMID: 16919268
  31. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.
    Cancer Res. 2000 Feb 15;60(4):1077-83 PMID: 10706127
  32. Shaping of tumor and drug-resistant genomes by instability and selection.
    Oncogene. 2003 Jul 10;22(28):4370-9 PMID: 12853973
  33. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines.
    Cancer Res. 2004 Jan 1;64(1):40-7 PMID: 14729606
  34. Chromosomal instability and lack of cyclin E regulation in hCdc4 mutant human breast cancer cells.
    Breast Cancer Res. 2004;6(5):R531-9 PMID: 15318934
  35. CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
    Genes Chromosomes Cancer. 1998 Aug;22(4):268-77 PMID: 9669664
  36. Genomic analysis of the 8p11-12 amplicon in familial breast cancer.
    Int J Cancer. 2007 Feb 1;120(3):714-7 PMID: 17096335
  37. p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21.
    Cancer Res. 2007 Oct 15;67(20):9862-8 PMID: 17942917
  38. Assembly of microarrays for genome-wide measurement of DNA copy number.
    Nat Genet. 2001 Nov;29(3):263-4 PMID: 11687795
  39. Comprehensive profiling of 8p11-12 amplification in breast cancer.
    Mol Cancer Res. 2005 Dec;3(12):655-67 PMID: 16380503
  40. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
    Clin Cancer Res. 2004 Sep 1;10(17):5785-91 PMID: 15355907
  41. Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
    BMC Cancer. 2006 Oct 13;6:245 PMID: 17040570
  42. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.
    Cancer Cell. 2006 Dec;10(6):529-41 PMID: 17157792
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
1476-5594
Published
2009-04-30
Epub
2009-00-30
Pages
1892-903
Language
English
Region
England
NLM ID
8711562
PMCID
PMC2722962
Subset
IM
Grants
NCI NIH HHS · R01 CA090421 · United States
NCI NIH HHS · R01 CA090421-01A2 · United States
NCI NIH HHS · CA90421 · United States
NCI NIH HHS · R01 CA101359 · United States
NCI NIH HHS · CA101359 · United States
NCI NIH HHS · R01 CA101359-01 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]